| Quantity | 20 nmol, 50 nmol, 100 nmol, 200 nmol | 5 slides | 1mg | 1mg | 20 nmol, 50 nmol, 100 nmol, 200 nmol |
| Description | The product SIRGT14253WQ-LNA is a type of small interfering RNA (siRNA) that targets IGF1 gene and regulates the expression of gene. The siRNA interferes with the expression of IGF1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA The product SIRGT14253WQ-LNA is a type of small interfering RNA (siRNA) that targets IGF1 gene and regulates the expression of gene. The siRNA interferes with the expression of IGF1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.... Read More | Creative Biolabs' Neuropathy Frozen Tissue Panels are designed for the study of Alzheimer's disease, Parkinson's disease, dementia, multiple sclerosis, progressive supranuclear palsy (PSP) and depression. | This membrane protein is Rat IL-2 R beta&IL-2 R gamma. We provide this protein to facilitate your membrane protein antibody discovery and development. | This product is a 58 kDa Human SPNS2 membrane protein expressed in HEK293. The protein is for research use only and is not approved for use in humans or in clinical diagnosis. | The product SIRGT45322WQ is a type of small interfering RNA (siRNA) that targets KIAA0319L gene and regulates the expression of gene. The siRNA interferes with the expression of KIAA0319L gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. It The product SIRGT45322WQ is a type of small interfering RNA (siRNA) that targets KIAA0319L gene and regulates the expression of gene. The siRNA interferes with the expression of KIAA0319L gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. It has potential applications in RNA interference (RNAi) and gene therapy development.... Read More |